OSCR

5-HT4 Receptor Ligand RS67333 Modulates Striatal Acetylcholine and Dopamine Release via the Inhibition of Acetylcholinesterase.

Overview

Authors: Qinbo Qiao1,2,3, Wenhui Wu1,2,3, Stephanie J. Cragg1,2,3
  1. Centre for Cellular and Molecular Neuroscience, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3PT, United Kingdom
  2. Oxford Parkinson’s Disease Centre, University of Oxford, Oxford OX1 3PT, United Kingdom
  3. Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, Maryland 20815, United States
Institutions: University of Oxford (United Kingdom); Aligning Science Across Parkinson's (United States)
Journal: ACS chemical neuroscience, volume 17, issue 15, pages 3013-3022
Dates: received 8 May 2026; accepted 7 July 2026; published online 20 July 2026; in print August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1021/acschemneuro.6c00342 · PMID 42477514 · PMCID PMC13449880 · OpenAlex W7169793023
Open access: hybrid, a free copy (OpenAlex)
Categories: mouse (organism), cellular / molecular (subfield)
Methods: Statistics, Evoked potentials, fMRI & imaging, Single-unit activity, calcium imaging
Keywords: striatum, 5-HT4 receptors, RS67333, serotonin, dopamine, acetylcholine, acetylcholinesterase, nicotinic receptors, GRAB sensors, voltammetry
MeSH: Acetylcholine*, Acetylcholinesterase*, Cholinesterase Inhibitors*, Corpus Striatum*, Dopamine*, Pyridines*, Receptors, Serotonin, 5-HT4*, Serotonin 5-HT4 Receptor Agonists*, Aniline Compounds, Animals, Ligands, Male, Mice, Mice, Inbred C57BL, Piperidines (* major topic)
Topic: Cholinesterase and Neurodegenerative Diseases (Pharmacology (medical), Medicine), according to OpenAlex
Funding: Michael J. Fox Foundation for Parkinson’s Research (ASAP-020370, ASAP-025192)
Citations: not cited yet (Europe PMC); 57 references in the paper

Abstract

Serotonin 5-HT4 receptors (5-HT4Rs) have emerged as potential therapeutic targets in neuropsychiatric and neurodegenerative disorders by modulating circuits that shape mood, cognition, and motor functions. Ligands for 5-HT4Rs can modify dopamine (DA) and acetylcholine (ACh) transmission, but mechanisms and circuits have not been fully resolved. Some 5-HT4R agonists have been suggested to have effects that include the inhibition of acetylcholinesterase (AChE), raising the speculation that 5-HT4R ligands might modulate ACh and DA through this action. Here, we investigated the impact of RS67333, a partial 5-HT4R agonist, on DA and ACh release dynamics in the striatum detected ex vivo in mouse brain slices using fast-scan cyclic voltammetry (FCV) and genetically encoded ACh sensor GRABACh3.0, respectively. We found that RS67333 significantly modulated electrically evoked DA release in the dorsolateral striatum (DLS) and nucleus accumbens core, effects that were abolished by a nicotinic receptor (nAChR) antagonist. In parallel, RS67333 altered evoked ACh signals by extending extracellular ACh lifetime, and correspondingly, RS67333 was found to inhibit striatal AChE enzymatic activity. By contrast, BIMU8, an alternative 5-HT4R ligand that did not inhibit striatal AChE, had no effect on the evoked striatal ACh or DA release. These findings indicate that RS67333 modulates striatal ACh transmission, which shapes downstream regulation of DA release by nAChRs, not through 5-HT4Rs but through AChE inhibition. These findings emphasize the caution due in attributing functions to 5-HT4Rs but also highlight an alternative pharmacological profile of some purported 5-HT4R ligands as AChE inhibitors of potential utility for treating ACh/DA disorders.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

The source data, as well as protocols, key lab materials, and code used and generated in this study are listed in a Key Resource Table and available alongside their persistent identifiers at https://doi.org/10.5281/zenodo.17278002.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 3, 28 September 2026

  • Publisher: n/a → American Chemical Society

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 10 keywords, 15 MeSH terms, 1 funder, 56 references.

Cite

This paper

Qiao, Q., Wu, W., & Cragg, S. J. (2026). 5-HT4 Receptor Ligand RS67333 Modulates Striatal Acetylcholine and Dopamine Release via the Inhibition of Acetylcholinesterase. ACS chemical neuroscience, 17(15), 3013-3022. https://doi.org/10.1021/acschemneuro.6c00342

BibTeX

@article{qiao20265,
author = {Qiao, Qinbo and Wu, Wenhui and Cragg, Stephanie J.},
title = {{5-HT4 Receptor Ligand RS67333 Modulates Striatal Acetylcholine and Dopamine Release via the Inhibition of Acetylcholinesterase}},
journal = {ACS chemical neuroscience},
year = {2026},
month = aug,
volume = {17},
number = {15},
pages = {3013--3022},
publisher = {American Chemical Society},
issn = {1948-7193},
doi = {10.1021/acschemneuro.6c00342},
url = {https://doi.org/10.1021/acschemneuro.6c00342},
pmid = {42477514},
pmcid = {PMC13449880}
}

RIS

TY - JOUR
AU - Qiao, Qinbo
AU - Wu, Wenhui
AU - Cragg, Stephanie J.
TI - 5-HT4 Receptor Ligand RS67333 Modulates Striatal Acetylcholine and Dopamine Release via the Inhibition of Acetylcholinesterase
T2 - ACS chemical neuroscience
J2 - ACS Chem Neurosci
PY - 2026
DA - 2026/08/01
VL - 17
IS - 15
SP - 3013
EP - 3022
SN - 1948-7193
PB - American Chemical Society
DO - 10.1021/acschemneuro.6c00342
UR - https://doi.org/10.1021/acschemneuro.6c00342
LA - en
ER -

CSL-JSON

{
"id": "10.1021/acschemneuro.6c00342",
"type": "article-journal",
"title": "5-HT4 Receptor Ligand RS67333 Modulates Striatal Acetylcholine and Dopamine Release via the Inhibition of Acetylcholinesterase",
"container-title": "ACS chemical neuroscience",
"author": [
{
"family": "Qiao",
"given": "Qinbo"
},
{
"family": "Wu",
"given": "Wenhui"
},
{
"family": "Cragg",
"given": "Stephanie J."
}
],
"container-title-short": "ACS Chem Neurosci",
"volume": "17",
"issue": "15",
"page": "3013-3022",
"DOI": "10.1021/acschemneuro.6c00342",
"PMID": "42477514",
"PMCID": "PMC13449880",
"ISSN": "1948-7193",
"publisher": "American Chemical Society",
"URL": "https://doi.org/10.1021/acschemneuro.6c00342",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41593-025-01906-5 [code]
An axonal brake on striatal dopamine output by cholinergic interneurons.
Journal: Nature neuroscience
In common: mouse, cellular / molecular, 9 references, author Stephanie J. Cragg
[2] doi:10.1038/s41467-024-54253-7 [code]
Rapid modulation of striatal cholinergic interneurons and dopamine release by satellite astrocytes.
Journal: Nature communications
In common: mouse, cellular / molecular, 6 references, author Stephanie J. Cragg
[3] doi:10.1111/ejn.16180
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Journal: The European journal of neuroscience
In common: mouse, cellular / molecular, 5 references, author Stephanie J. Cragg
[4] doi:10.1038/s41467-026-73906-3 [code]
A synaptic mechanism for encoding the learned value of action-derived safety.
Journal: Nature communications
In common: mouse, cellular / molecular, 6 references
[5] doi:10.3389/fpsyt.2022.859123 [code]
The Effect of the 5-HT<sub>4</sub> Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain.
Journal: Frontiers in psychiatry
In common: 5 references
[6] doi:10.1016/j.isci.2022.105332
Developmental regulation of thalamus-driven pauses in striatal cholinergic interneurons.
Journal: iScience
In common: mouse, 5 references
[7] doi: [code]
5-HT4 Receptor Agonist Effects on Functional Connectivity in the Human Brain: Implications for Procognitive Action
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
In common: cellular / molecular, 4 references
[8] doi:10.1038/s41467-026-72167-4 [code]
The superior colliculus gates dopamine responses to conditioned stimuli in visual classical conditioning.
Journal: Nature communications
In common: mouse, cellular / molecular, 1 reference, author Stephanie J. Cragg
[9] doi:10.7554/elife.75398 [code]
Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2.
Journal: eLife
In common: mouse, cellular / molecular, 1 reference, author Stephanie J. Cragg
[10] doi:10.7554/elife.95694 [code]
Comment on 'Accumbens cholinergic interneurons dynamically promote dopamine release and enable motivation'.
Journal: eLife
In common: mouse, 4 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.